… syndromes characterized by elevated levels of free IL-18 might benefit from such a therapy,
and this warrants further investigation. Although IL-33 is also an IL-1 family member, it is …

… therapies are being explored to dampen the cytokine storm … 19 cytokine storm syndrome was
targeting interleukin-6 (IL-6)… potential benefit in treating COVID-19 cytokine storm syndrome…

… are required to explore the clinical benefits of blood purification for cytokine storms induced
by SARS-CoV-2 infection. Similarly, other factors for this therapy, such as the appropriate …

… therapeutic drugs or vaccines are available to treat COVID-19. In this review, we intended to
describe how cytokine storm is … response due to cytokine storm during COVID-19 infection …

… a cytokine storm remains limited. In this review, we focus on the potential mechanisms
responsible for severe influenza-induced cytokine storm and the therapeutic … additional benefits …

… Finally, it is noteworthy that in seriously ill COVID-19 patients, relevant therapeutic benefits
can be obtained by associating tocilizumab in combined treatments with corticosteroids, …

… Hyperinflammation due to excessive cytokine release in … immunomodulatory candidates
for the cytokine release syndrome (… efficacy of both synthetic and natural therapeutic drugs for …

… -2-induced cytokine storm grows, it will become more apparent what subset of patients and
at what disease stage could benefit the most from anti-inflammatory therapies. In parallel to …

… to choose a specific therapy and simultaneously measure the … In other words, applying the
right therapeutic approach at the … -designed therapeutic trials—otherwise, the potential benefit …

… syndromes characterized by cytokine storms, such as the cytokine release syndrome (CRS), …
of therapeutic opportunity,” a phase of the disease during which the benefits of cytokine …